Pharmacotherapy for adults with overweight and obesity - Authors' reply

Affiliations

¹ Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
² Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: lisheyu@scu.edu.cn.

Comment

Qingyang Shi et al. Lancet. 2022.

. 2022 Jun 4;399(10341):2101.

doi: 10.1016/S0140-6736(22)00786-3.

¹ Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
² Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: lisheyu@scu.edu.cn.

No abstract available

Comment on

Pharmacotherapy for adults with overweight and obesity.
Sturgiss E, Ball L, Blane D, Hennessy M, Quigley F. Sturgiss E, et al. Lancet. 2022 Jun 4;399(10341):2100-2101. doi: 10.1016/S0140-6736(22)00787-5. Lancet. 2022. PMID: 35658990 No abstract available.